These findings were challenged by other studies indicating that CD271 expression on patient melanoma cells is unstable and not linked to tumorigenicity: in fact, CD271+ and CD271− primary melanoma cells were found to be similarly tumorigenic using various specific assays [236]. The gene discussed is NGFR; the disease is melanoma.